IUHSA
ATRA icon

Itau Unibanco Holding S.A.’s Atara Biotherapeutics ATRA Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-171
Closed -$12.4K – 517
2023
Q1 		$12.4K Hold
171
– – ﹤0.01% 438
2022
Q4 		$14K Buy
171
+18
+12% +$1.88K ﹤0.01% 433
2022
Q3 		$14K Buy
+153
New +$17.2K ﹤0.01% 476

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Itau Unibanco Holding S.A.'s ATRA Position: Q2 2023 in Review

Itau Unibanco Holding S.A. sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 171 shares — an estimated $12.4K sold.

Itau Unibanco Holding S.A. first reported a position in ATRA in Q3 2022 and held it in 3 quarters. The position peaked at $14K in Q4 2022. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Itau Unibanco Holding S.A. reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 171 Atara Biotherapeutics shares in Q2 2023, an estimated $12.4K.
  • Itau Unibanco Holding S.A. first reported a position in Atara Biotherapeutics in Q3 2022 and held it in 3 quarters.
  • Itau Unibanco Holding S.A.'s Atara Biotherapeutics position peaked at $14K in Q4 2022.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2023, filed 14 Aug 2023.